STAT3 and posterior cortical atrophy: Accordingly, combined inhibition of EGFR and STAT3 using Erlotinib and TTI‐101, respectively, led to a significant reduction in 2D and 3D cell growth of early and advanced PCa cells overexpressing ETV1.